FindTrial
Sign In

A study to compare the effects of combination of Ropivacaine and Nalbuphine with Ropivacaine alone in patients undergoing upper limb surgery under regional anaesthesia

A study to compare the effects of combination of 0.5% Ropivacaine and Nalbuphine with 0.5% Ropivacaine alone for Ultrasound guided Supraclavicular Brachial plexus block in patients undergoing upper limb surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/017983
Enrollment
100
Registered
2019-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

Intervention1: 0.5% ropivacaine for regional block: Evaluate the effects of 0.5% ropivacaine alone for ultrasound guided supraclavicular brachial plexus block in patients undergoing upper limb surgery

Sponsors

Jln medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient aged between 18-70 years 2. ASA physical status I and II 3. Upper limb surgery distal to mid arm level

Exclusion criteria

Exclusion criteria: 1 Patient refusal 2 Patient sensitive / allergic to opioid and local anaesthetic agents 3 Patients with peripheral sensorineural deficit 4 Patients on anticoagulants. 5 Infection at the site of block performance 6 Suspected compartment syndrome in the upper limbs

Design outcomes

Primary

MeasureTime frame
1 Onset and duration of sensory block. 2 Onset and duration of motor block. 3 Duration of postoperative analgesia Timepoint: 6 Months—

Secondary

MeasureTime frame
1 Haemodynamic parametersTimepoint: 6 Months;2 Side effects / Complications like: - Nausea - Vomiting - Horners syndrome - Respiratory depression Timepoint: 6 Months—

Countries

India

Contacts

Public ContactDr kavita jain

jln medical college ajmer

drkavitajain15@gmail.com9414006151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026